论文部分内容阅读
目的探讨盐酸氨溴索注射液治疗儿科呼吸系统疾病的疗效。方法择于2014年9月至2015年8月于我院儿科进行就医的呼吸系统疾病患儿78例,将他们按照随机数表均分为实验组与参考组,每组39例,实验组患儿采用盐酸氨溴索注射液治疗,而参考组病人采用一般的布地奈德雾化吸入治疗,统计各组病人治疗有效率情况,并且对比分析。结果在完成治疗后,根据两组病人的治疗有效率统计数据可知,实验组显效15例,有效22例,无效或者恶化1例,治疗有效率为97.43%;而参考组显效10例,有效15例,无效或者恶化14例,治疗有效率为56.41%,以上组间数据存在显著差异,具有统计学意义(P<0.05)。结论相对于传统布地奈德雾化吸入治疗,盐酸氨溴索注射液对儿科呼吸系统疾病治疗效果更加明显,具有临床推广意义。
Objective To investigate the efficacy of ambroxol hydrochloride injection in the treatment of pediatric respiratory diseases. Methods From September 2014 to August 2015, 78 children with respiratory diseases undergoing pediatric medical treatment in our hospital were divided into experimental group and reference group according to random number table, with 39 cases in each group. The patients in experimental group Children treated with ambroxol hydrochloride injection, while the reference group of patients with general budesonide inhalation therapy, statistical treatment of patients in each group efficiency, and comparative analysis. Results After the completion of treatment, according to the statistics of treatment efficiency of the two groups of patients, the experimental group markedly effective in 15 cases, effective in 22 cases, invalid or worse in 1 case, the effective rate was 97.43%; while the reference group markedly effective in 10 cases, effective 15 Cases, invalid or worsened in 14 cases, the effective rate was 56.41%, the data between the above groups were significantly different, with statistical significance (P <0.05). Conclusion Compared with the traditional inhalation of budesonide inhalation, ambroxol hydrochloride injection is more effective in treating pediatric respiratory diseases and has clinical significance.